Epigral Limited (NSE: EPIGRAL), ISIN INE071N01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
EPIGRAL last traded at ₹1113.95 (-1.06%), with a 52-week range of ₹806.20 to ₹2114.30 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 68.83%, FIIs 1.03%, DIIs 5.56%, mutual funds 5.52%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.